+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Proteasome Inhibitors Market 2025-2029 - Product Thumbnail Image

Proteasome Inhibitors Market 2025-2029

  • Report
  • May 2025
  • 243 Pages
  • Global
From
Bispecific Antibodies for Cancer Market 2025-2029 - Product Thumbnail Image

Bispecific Antibodies for Cancer Market 2025-2029

  • Report
  • February 2025
  • 233 Pages
  • Global
From
CAR T-cell Therapy Market 2025-2029 - Product Thumbnail Image

CAR T-cell Therapy Market 2025-2029

  • Report
  • January 2025
  • 199 Pages
  • Global
From
Antibody Drug Conjugates Market 2025-2029 - Product Thumbnail Image

Antibody Drug Conjugates Market 2025-2029

  • Report
  • January 2025
  • 189 Pages
  • Global
From
Small Molecule API Market 2024-2028 - Product Thumbnail Image

Small Molecule API Market 2024-2028

  • Report
  • November 2024
  • 159 Pages
  • Global
From
Bile Duct Cancer Market 2024-2028 - Product Thumbnail Image

Bile Duct Cancer Market 2024-2028

  • Report
  • October 2024
  • 136 Pages
  • Global
From
Hedgehog Pathway Inhibitors Market 2024-2028 - Product Thumbnail Image

Hedgehog Pathway Inhibitors Market 2024-2028

  • Report
  • October 2024
  • 143 Pages
  • Global
From
Janus Kinase (JAK) Inhibitors Market 2024-2028 - Product Thumbnail Image

Janus Kinase (JAK) Inhibitors Market 2024-2028

  • Report
  • October 2024
  • 145 Pages
  • Global
From
From
B-Cell Non-Hodgkin's Lymphoma: Epidemiology Forecast to 2033 - Product Thumbnail Image

B-Cell Non-Hodgkin's Lymphoma: Epidemiology Forecast to 2033

  • Report
  • March 2025
  • 55 Pages
  • Global
From
Myelodysplastic Syndrome: Competitive Landscape - Product Thumbnail Image

Myelodysplastic Syndrome: Competitive Landscape

  • Report
  • February 2025
  • 84 Pages
  • Global
From
From
Prostate Cancer: Epidemiology Forecast to 2033 - Product Thumbnail Image

Prostate Cancer: Epidemiology Forecast to 2033

  • Report
  • February 2025
  • 51 Pages
  • Global
From
Innovation Insights: Antibody-drug conjugates - Product Thumbnail Image

Innovation Insights: Antibody-drug conjugates

  • Report
  • January 2025
  • 54 Pages
  • Global
From
Myelodysplastic Syndrome - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Myelodysplastic Syndrome - Global Clinical Trials Review, 2025

  • Clinical Trials
  • January 2025
  • 2143 Pages
  • Global
From
Bile Duct Cancer (Cholangiocarcinoma) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Bile Duct Cancer (Cholangiocarcinoma) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • December 2024
  • 1394 Pages
  • Global
From
Esophageal Cancer: Competitive Landscape - Product Thumbnail Image

Esophageal Cancer: Competitive Landscape

  • Report
  • October 2024
  • 88 Pages
  • Global
From
Transitional Cell Carcinoma Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Transitional Cell Carcinoma Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Tenosynovial Giant Cell Tumors Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Tenosynovial Giant Cell Tumors Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more